Current and new directions in MRI in multiple sclerosis

CONTINUUM Lifelong Learning in Neurology

Volumn 19, Issue 4, 2013, Pages 1058-1073

  Klawiter, Eric C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; N ACETYLASPARTIC ACID;

ANISOTROPY; BOLD SIGNAL; BRAIN ATROPHY; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CORPUS CALLOSUM; DEFAULT MODE NETWORK; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSION; DIFFUSION TENSOR IMAGING; DIPLOPIA; DISEASE ACTIVITY; FLUID ATTENUATED INVERSION RECOVERY IMAGING; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PROTON NUCLEAR MAGNETIC RESONANCE; PYRAMIDAL TRACT; REVIEW; SENSITIVITY AND SPECIFICITY; SPINAL CORD; VERTIGO; WHITE MATTER;

ADULT; ATROPHY; BRAIN; BRAIN DISEASES; DIPLOPIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROIMAGING; SPINAL CORD DISEASES; VERTIGO;

EID: 84881639011     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000433283.00221.37     Document Type: Review

References (49)

1. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69(2):292-302.
2. Sati P, George IC, Shea CD, et al. FLAIR: A combined MR contrast technique for visualizing white matter lesions and parenchymal veins. Radiology 2012:265(3): 926-932.
3. Tallantyre EC, Dixon JE, Donaldson I, et al. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology 2011;76(6):534-539.
4. Sinnecker T, Dorr J, Pfueller CF, et al. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 2012;79(7):708-714.
5. Pelletier J, Habib M, Lyon-Caen O, et al. Functional and magnetic resonance imaging correlates of callosal involvement in multiple sclerosis. Arch Neurol 1993;50(10): 1077-1082.
6. Cotton F, Weiner HL, Jolesz FA, Guttmann CR. MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 2003;60(4):640-646.
7. Hawker K, O'Connor P, Freedman MS, et al. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol 2009;66(4):460-471.
8. Masdeu JC, Moreira J, Trasi S, et al. The open ring. A new imaging sign in demyelinating disease. J Neuroimaging 1996;6(2):104-107.
9. Gaitan MI, Shea CD, Evangelou IE, et al. Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol 2011;70(1):22-29.
10. Bagnato F, Jeffries N, Richert ND, et al. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain 2003;126(pt 8):1782-1789.
11. van Walderveen MA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50(5):1282-1288.
12. Chard DT, Griffin CM, Parker GJ, et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125(pt 2): 327-337.
13. Ge Y, Grossman RI, Udupa JK, et al. Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter. Radiology 2001;220(3):606-610.
14. Rudick RA, Lee JC, Nakamura K, Fisher E. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. J Neurol Sci 2009;282(1-2): 106-111.
15. Shiee N, Bazin PL, Zackowski KM, et al. Revisiting brain atrophy and its relationship to disability in multiple sclerosis. PLoS One 2012;7(5):e37049.
16. Barkhof F, Calabresi PA, Miller DH, Reingold SC. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 2009;5(5):256-266.
17. Yaldizli O, Atefy R, Gass A, et al. Corpus callosum index and long-term disability in multiple sclerosis patients. J Neurol 2010; 257(8):1256-1264.
18. Houtchens MK, Benedict RH, Killiany R, et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007;69(12): 1213-1223.
19. Rocca MA, Mesaros S, Pagani E, et al. Thalamic damage and long-term progression of disability in multiple sclerosis. Radiology 2010;257(2):463-469.
20. Calabrese M, Rinaldi F, Mattisi I, et al. The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology 2011;77(3):257-263.
21. Sicotte NL, Kern KC, Giesser BS, et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2008;131(pt 14): 1134-1141.
22. Bot JC, Barkhof F, Polman CH, et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 2004;62(2): 226-233.
23. Cassinotto C, Deramond H, Olindo S, et al. MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis. J Neuroradiol 2009;36(4):199-205.
24. Romeo M, Martinelli V, Perego M, et al. Brain MRI activity after disease-modifying treatment may predict disability progression after 5 years in relapsing remitting multiple sclerosis patients [abstract]. Amsterdam, The Netherlands: Proceedings of the 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis, 2011; 30; Abstract nr 29.
25. Song SK, Sun SW, Ramsbottom MJ, et al. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002;17(3): 1429-1436.
26. Naismith RT, Xu J, Tutlam NT, et al. Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology 2010;74(21):1694-1701.
27. Moll NM, Rietsch AM, Thomas S, et al. Multiple sclerosis normal-appearing white matter: pathology-imaging correlations. Ann Neurol 2011;70(5):764-773.
28. Fox RJ, Sakaie K, Lee JC, et al. A validation study of multicenter diffusion tensor imaging: reliability of fractional anisotropy and diffusivity values. AJNR Am J Neuroradiol 2012;33(4):695-700.
29. Schmierer K, Scaravilli F, Altmann DR, et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004;56(3):407-415.
30. Chen JT, Collins DL, Atkins HL, et al. Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Ann Neurol 2008;63(2):254-262.
31. van den Elskamp IJ, Knol DL, Vrenken H, et al. Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis. Mult Scler 2010;16(6):660-669.
32. Abdel-Fahim R, Mistry N, Mougin O, et al. Improved detection of cortical lesions using 7T magentisation transfer imaging in patients with multiple sclerosis [abstract]. Lyon, France: Proceedings of the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, 2012; 50. Abstract nr 146.
33. Rigotti DJ, Inglese M, Kirov, II, et al. Two-year serial whole-brain N-acetyl-Laspartate in patients with relapsingremitting multiple sclerosis. Neurology 2012;78(18):1383-1389.
34. Llufriu S, Kornak J, Ratinev H, et al. MR spectroscopy markers of disease progression in multiple sclerosis: a clinical validation study. Neurology 2012;78:PL01.002.
35. Wood ET, Ronen I, Techawiboonwong A, et al. Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy. J Neurosci 2012;32(19): 6665-6669.
36. Cohen AB, Neema M, Arora A, et al. The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis. J Neuroimaging 2012;22(2):122-128.
37. Klawiter EC, Xu J, Naismith RT, et al. Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis. Mult Scler 2012;18(9): 1259-1268.
38. Oh J, Zackowski K, Chen M, et al. Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis [published online ahead of print August 13, 2013. Mult Scler. doi:10.1177/1352458512456614.
39. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128(pt 11):2705-2712.
40. Nelson F, Datta S, Garcia N, et al. Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis. Mult Scler 2011;17(9): 1122-1129.
41. Geurts JJ, Roosendaal SD, Calabrese M, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 2011;76(5): 418-424.
42. de Graaf WL, Kilsdonk ID, Lopez-Soriano A, et al. Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter. Eur Radiol 2012;23(2):528-540.
43. Mainero C, Benner T, Radding A, et al. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 2009;73(12):941-948.
44. Cohen-Adad J, Benner T, Greve D, et al. In vivo evidence of disseminated subpial T2. signal changes in multiple sclerosis at 7 T: a surface-based analysis. Neuroimage 2011;57(1):55-62.
45. Pitt D, Boster A, Pei W, et al. Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging. Arch Neurol 2010;67(7):812-818.
46. Raichle ME, Mintun MA. Brain work and brain imaging. Annu Rev Neurosci 2006; 29:449-476.
47. Wahl M, Hubers A, Lauterbach-Soon B, et al. Motor callosal disconnection in early relapsing-remitting multiple sclerosis. Hum Brain Mapp 2011;32(6):846-855.
48. Roosendaal SD, Schoonheim MM, Hulst HE, et al. Resting state networks change in clinically isolated syndrome. Brain 2010;133(pt 6):1612-1621.
49. Rocca MA, Valsasina P, Absinta M, et al. Default-mode network dysfunction and cognitive impairment in progressive MS. Neurology 2010;74(16):1252-1259.